Login to your account

Username *
Password *
Remember Me
Cohort study: High thrombotic risk in cancer patients receiving immunotherapy

Cohort study: High thrombotic risk in cancer patients receiving immunotherapy

High thrombotic risk in cancer patients receiving immunotherapy – Medical University of Vienna Original study: Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy – Blood  

The post Cohort study: High thrombotic risk in cancer patients receiving immunotherapy appeared first on Links Medicus.

Lu 613 fois
Évaluer cet élément
(0 Votes)

About Author

Laissez un commentaire

Assurez-vous d'entrer toutes les informations requises, indiquées par un astérisque (*). Le code HTML n'est pas autorisé.